Gilla Kaplan
InvestorBoard Member at Avalo Therapeutics
About
Recognized authority on host immune response to mycobacterial pathogens including agents causing leprosy and tuberculosis. Previously Director of Global Health Tuberculosis program at Bill & Melinda Gates Foundation (2014–2018). Spent 20 years at Rockefeller University and 10 years at Public Health Research Institute Center leading immunology research and receiving multiple NIH-NIAID grants.
Colleagues at Avalo Therapeutics
Aaron Kantoff
Board Member at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Kathleen Cohen
Senior Vice President, Clinical Development Operations at Avalo Therapeutics